BTS
HRTX icon

BB&T Securities’s Heron Therapeutics HRTX Stock Holding History

BB&T Securities’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$200K Buy
+10,845
New +$200K ﹤0.01% 1514
2018
Q3 		– Sell
-14,017
Closed -$544K – 1607
2018
Q2 		$544K Sell
14,017
-1,495
-10% -$47.6K 0.01% 1038
2018
Q1 		$428K Buy
+15,512
New +$352K ﹤0.01% 1084

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BB&T Securities's HRTX Position: Q3 2019 in Review

BB&T Securities opened a new position in Heron Therapeutics (HRTX) in Q3 2019: 10,845 shares worth $200K. The stake represents ﹤0.01% of the portfolio and ranks #1514 among its holdings. This is a return to the name: BB&T Securities previously reported a position in HRTX as recently as Q2 2018.

BB&T Securities first reported a position in HRTX in Q1 2018 and has held it in 3 quarters since. The position peaked at $544K in Q2 2018. 180 funds tracked by Wall St. Rank hold HRTX as of Q3 2019.

  • BB&T Securities held 10,845 shares of Heron Therapeutics worth $200K as of Q3 2019.
  • Heron Therapeutics was a new BB&T Securities position in Q3 2019.
  • Heron Therapeutics made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1514 holding.
  • BB&T Securities first reported a position in Heron Therapeutics in Q1 2018 and has held it in 3 quarters since.
  • BB&T Securities's Heron Therapeutics position peaked at $544K in Q2 2018.
  • 180 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.